Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Vogel

Showing results (411-420 of 456) with videos related to

Pageof 46
Sort By:
Nature Immunology|April 27, 2005
Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105Senad Divanovic, Aurelien Trompette, Sowsan F Atabani, et al.
Gastroenterology|May 20, 2008
Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3Karen M Lammers, Ruliang Lu, Julie Brownley, et al.
Clinical and Vaccine Immunology : CVI|December 20, 2013
Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strainKatharina Richard, Barbara J Mann, Lenea Stocker, et al.
Cancers|April 30, 2021
Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder CancerThomas Albrecht, Fritz Brinkmann, Michael Albrecht, et al.
Vaccine|May 12, 2020
Dissociation of TRIF bias and adjuvanticityKatharina Richard, Darren J Perkins, Erin M Harberts, et al.
Cellular Immunology|January 5, 2023
Full-length IL-33 augments pulmonary fibrosis in an ST2- and Th2-independent, non-transcriptomic fashionIrina G Luzina, Virginia Lockatell, Jean-Paul Courneya, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2015
Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domainPragnesh Mistry, Michelle H W Laird, Ryan S Schwarz, et al.
Plos One|April 13, 2012
Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complexChiguang Feng, Nicholas M Stamatos, Anatoliy I Dragan, et al.
The Journal of Experimental Medicine|June 15, 2007
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axisZachary J Roberts, Nadege Goutagny, Pin-Yu Perera, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 8, 2020
Interferon-β Plays a Detrimental Role in Experimental Traumatic Brain Injury by Enhancing Neuroinflammation That Drives Chronic NeurodegenerationJames P Barrett, Rebecca J Henry, Kari Ann Shirey, et al.
Pageof 46

Showing results (411-420 of 456) with videos related to

Sort By:
Pageof 46
Nature Immunology|April 27, 2005
Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105Senad Divanovic, Aurelien Trompette, Sowsan F Atabani, et al.
Gastroenterology|May 20, 2008
Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3Karen M Lammers, Ruliang Lu, Julie Brownley, et al.
Clinical and Vaccine Immunology : CVI|December 20, 2013
Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strainKatharina Richard, Barbara J Mann, Lenea Stocker, et al.
Cancers|April 30, 2021
Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder CancerThomas Albrecht, Fritz Brinkmann, Michael Albrecht, et al.
Vaccine|May 12, 2020
Dissociation of TRIF bias and adjuvanticityKatharina Richard, Darren J Perkins, Erin M Harberts, et al.
Cellular Immunology|January 5, 2023
Full-length IL-33 augments pulmonary fibrosis in an ST2- and Th2-independent, non-transcriptomic fashionIrina G Luzina, Virginia Lockatell, Jean-Paul Courneya, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2015
Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domainPragnesh Mistry, Michelle H W Laird, Ryan S Schwarz, et al.
Plos One|April 13, 2012
Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complexChiguang Feng, Nicholas M Stamatos, Anatoliy I Dragan, et al.
The Journal of Experimental Medicine|June 15, 2007
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axisZachary J Roberts, Nadege Goutagny, Pin-Yu Perera, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 8, 2020
Interferon-β Plays a Detrimental Role in Experimental Traumatic Brain Injury by Enhancing Neuroinflammation That Drives Chronic NeurodegenerationJames P Barrett, Rebecca J Henry, Kari Ann Shirey, et al.
Pageof 46